EVERY Company Secures $55 Million in Funding
The EVERY Company has secured $55 million in a Series D funding round, led by McWin Capital Partners, with participation from investors including Main Sequence, Bloom8, and Minerva Foods.
This funding will support the company's expansion into the US market as it scales up its production of precision-fermented egg proteins.
EVERY is proving that biomanufacturing has the potential to transform the food industry
Alternative to Traditional Egg Proteins
EVERY's fermentation-based technology offers alternatives to traditional egg proteins, including OvoPro™ and OvoBoost™, designed to replace conventional eggs in products such as baked goods, beverages, and protein supplements.
Author's summary: EVERY Company raises $55 million.
- Investment: $55 million
- Lead investor: McWin Capital Partners
- Products: OvoPro™, OvoBoost™